Cutler Group’s Clovis Oncology, Inc. CLVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-14,569
Closed -$17K 5598
2022
Q3
$17K Sell
14,569
-9,454
-39% -$14.7K ﹤0.01% 2750
2022
Q2
$43K Sell
24,023
-37,696
-61% -$55.6K ﹤0.01% 2056
2022
Q1
$124K Buy
+61,719
New +$121K 0.01% 1546
2021
Q1
Sell
-9,700
Closed -$65K 6547
2020
Q4
$46K Sell
9,700
-6,000
-38% -$30.3K ﹤0.01% 2082
2020
Q3
$91K Buy
15,700
+1,500
+11% +$8.97K 0.01% 1381
2020
Q2
$95K Sell
14,200
-7,000
-33% -$53K 0.01% 1341
2020
Q1
$134K Sell
21,200
-3,700
-15% -$29.7K 0.01% 1185
2019
Q4
$259K Buy
+24,900
New +$181K 0.02% 701
2019
Q1
Sell
-10,628
Closed -$266K 4978
2018
Q4
$190K Sell
10,628
-4,972
-32% -$102K 0.02% 663
2018
Q3
$458K Sell
15,600
-2,700
-15% -$105K 0.03% 499
2018
Q2
$832K Sell
18,300
-8,100
-31% -$394K 0.07% 305
2018
Q1
$1.39M Sell
26,400
-1,123
-4% -$65.5K 0.12% 165
2017
Q4
$1.87M Buy
27,523
+6,774
+33% +$474K 0.08% 185
2017
Q3
$1.71M Buy
20,749
+1,066
+5% +$84.5K 0.06% 231
2017
Q2
$1.84M Sell
19,683
-9,894
-33% -$605K 0.07% 236
2017
Q1
$1.88M Sell
29,577
-40,040
-58% -$2.43M 0.08% 220
2016
Q4
$3.09M Buy
69,617
+66,279
+1,986% +$2.33M 0.11% 130
2016
Q3
$120K Sell
3,338
-13,932
-81% -$299K 0.01% 1673
2016
Q2
$236K Sell
17,270
-20,713
-55% -$303K 0.01% 998
2016
Q1
$729K Buy
37,983
+25,846
+213% +$547K 0.05% 367
2015
Q4
$424K Buy
+12,137
New +$783K 0.02% 710

Other funds holding CLVS